BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31547058)

  • 21. Discovery and optimization of boronic acid based inhibitors of autotaxin.
    Albers HM; van Meeteren LA; Egan DA; van Tilburg EW; Moolenaar WH; Ovaa H
    J Med Chem; 2010 Jul; 53(13):4958-67. PubMed ID: 20536182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling.
    Keune WJ; Hausmann J; Bolier R; Tolenaars D; Kremer A; Heidebrecht T; Joosten RP; Sunkara M; Morris AJ; Matas-Rico E; Moolenaar WH; Oude Elferink RP; Perrakis A
    Nat Commun; 2016 Apr; 7():11248. PubMed ID: 27075612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors.
    Cui P; Tomsig JL; McCalmont WF; Lee S; Becker CJ; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1634-40. PubMed ID: 17257836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrafast and Predictive Mass Spectrometry-Based Autotaxin Assays for Label-Free Potency Screening.
    Bretschneider T; Luippold AH; Romig H; Bischoff D; Klinder K; Nicklin P; Rist W
    SLAS Discov; 2017 Apr; 22(4):425-432. PubMed ID: 28328321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An updated patent review of autotaxin inhibitors (2017-present).
    Tan Z; Lei H; Guo M; Chen Y; Zhai X
    Expert Opin Ther Pat; 2021 May; 31(5):421-434. PubMed ID: 33342311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autotaxin in liver fibrosis.
    Ikeda H; Yatomi Y
    Clin Chim Acta; 2012 Nov; 413(23-24):1817-21. PubMed ID: 22820036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autotaxin--an LPA producing enzyme with diverse functions.
    Nakanaga K; Hama K; Aoki J
    J Biochem; 2010 Jul; 148(1):13-24. PubMed ID: 20495010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC).
    Sun Y; Zhang W; Evans JF; Floreani A; Zou Z; Nishio Y; Qi R; Leung PS; Bowlus CL; Gershwin ME
    Autoimmun Rev; 2016 Aug; 15(8):795-800. PubMed ID: 27019050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a novel, cell-based autotaxin assay.
    Dobersalske C; Grundmann M; Timmermann A; Theisen L; Kölling F; Harris RC; Fuerstner C; Becker MS; Wunder F
    Anal Biochem; 2021 Oct; 630():114322. PubMed ID: 34343482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
    Okudaira S; Yukiura H; Aoki J
    Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Function and biological activities of the autotaxin-LPA axis].
    Li ZW; Zhao YR; Zhao C; Fu R; Li ZY
    Sheng Li Xue Bao; 2011 Dec; 63(6):601-10. PubMed ID: 22193457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation.
    Ortlepp C; Steudel C; Heiderich C; Koch S; Jacobi A; Ryser M; Brenner S; Bornhäuser M; Brors B; Hofmann WK; Ehninger G; Thiede C
    Exp Hematol; 2013 May; 41(5):444-461.e4. PubMed ID: 23377000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
    Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
    Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model.
    Nikolaou A; Ninou I; Kokotou MG; Kaffe E; Afantitis A; Aidinis V; Kokotos G
    J Med Chem; 2018 Apr; 61(8):3697-3711. PubMed ID: 29620892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.
    Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H
    Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decrease in circulating autotaxin by oral administration of prednisolone.
    Sumida H; Nakamura K; Yanagida K; Ohkawa R; Asano Y; Kadono T; Tamaki K; Igarashi K; Aoki J; Sato S; Ishii S; Shimizu T; Yatomi Y
    Clin Chim Acta; 2013 Jan; 415():74-80. PubMed ID: 23063960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autotaxin and LPA receptor signaling in cancer.
    Houben AJ; Moolenaar WH
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis.
    Uranbileg B; Ito N; Kurano M; Kano K; Uchida K; Sumitani M; Aoki J; Yatomi Y
    Sci Rep; 2021 Feb; 11(1):3984. PubMed ID: 33597645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-function relationships of autotaxin, a secreted lysophospholipase D.
    Hausmann J; Perrakis A; Moolenaar WH
    Adv Biol Regul; 2013 Jan; 53(1):112-7. PubMed ID: 23069371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode.
    Miller LM; Keune WJ; Castagna D; Young LC; Duffy EL; Potjewyd F; Salgado-Polo F; Engel García P; Semaan D; Pritchard JM; Perrakis A; Macdonald SJ; Jamieson C; Watson AJ
    J Med Chem; 2017 Jan; 60(2):722-748. PubMed ID: 27982588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.